The largest database of trusted experimental protocols

10 protocols using dako envision flex

1

Immunohistochemical Analysis of CD45 in Tumor Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Representative areas for the amount of inflammation in each tumor were chosen. The immunostaining was done on 2.5 μm thick FFPE tumor tissue using a Dako Autostainer instrument (Dako, Agilent Technologies, Santa Clara, California, USA, model Link 48). Epitope retrieval was performed with Dako Flex HpH according to the manufacturer's protocol (Dako EnVision FLEX, Cat-no: K8000). Tissue sections were incubated for 20 min with primary anti-CD45 monoclonal antibodies (clones 2B11 and PD7/26, diluted 1:300; Dako, Cat-no: M0701). The secondary detection was performed with Dako EnVision TM Flex (Dako, Cat-no: K8000) for 20 min, followed by diaminobenzidine (DAB) staining for 10 min (Dako EnVision FLEX, Cat-no. K800021-2). The slides were thereafter treated with 0.5% CuSO4 for 5 min before counterstaining with hematoxylin (Merck, Cat-no: 1.15938.0100) to visualize cell nuclei. Tissue sections were examined with a Nikon Eclipse model N i-U microscope (Nikon, Tokyo, Japan) equipped with Nikon Plan-Fluor objective lenses (2×, 10×, 20×, 40×, and 60×) and images were taken with an Infinity 2 digital camera (Lumenera Corporation, Nepean, Ontario, Canada).
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of CD3 and CD20

Check if the same lab product or an alternative is used in the 5 most similar protocols
For light microscopy, 4 μm thick sections from formalin-fixed paraffin-embedded tissue were automatically stained with hematoxylin and eosin in a Sakura Tissue-Tek Prisma instrument (Sakura Finetek, Torrance, California, USA). The immunostainings were done on a Dako Autostainer instrument (Dako, Agilent Technologies, Santa Clara, California, USA, model Link 48), and the incubation time for the primary antibodies was 20 min. CD3 was immunostained by clone SP7 (a monoclonal rabbit antibody, diluted 1:150; Thermo Scientific, Waltham, Massachusetts, USA; cat. no. RM-9107), and CD20 was immunostained by clone L26 (a mouse IgG2a antibody, diluted 1:600; Dako, cat. no. M0755). The secondary detection was performed with Dako EnVision
TM Flex (Dako, cat. no. K8000) for 20 min, followed by diaminobenzidine (DAB) staining for 10 min. The slides were thereafter treated with CuSO4 for 5 min before contrastaining with hematoxylin. Samples were examined with a Nikon Eclipse model N
i-U microscope (Nikon, Tokyo, Japan) equipped with Nikon Plan-Fluor objective lenses (2×, 20×, and 40×) and images were taken with an Infinity 2 digital camera (Lumenera Corporation, Nepean, Ontario, Canada).
+ Open protocol
+ Expand
3

Immunocytochemistry and Immunohistochemistry of MPC1/MPC2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytoblocks were prepared for ICC and DakoEnVision™ Flex+ (K8012; Dako, Glostrup, Denmark) was applied for ICC and IHC staining as previously described [43 (link)]. After deparaffinization, unmasking epitopes and blocking of peroxidase, the slides were then incubated with the following reagents: rabbit monoclonal antibody against human MPC1(HPA045119, Sigma-Aldrich, St. Louis, MO, USA, diluted 1:500) and MPC2(ab111380, abcam, Cambridge, UK, diluted 1:500) at 4°C overnight. Negative controls were produced using the same concentration of non-immune rabbit IgG instead of the rabbit antibody to human MPC1 and MPC2.
+ Open protocol
+ Expand
4

Immunohistochemical Characterization of Neurodegeneration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The IHC stainings were carried out automatically or manually. The automated stainings were performed on the Dako Autostainer Plus (DakoCytomation, Glostrup, Denmark) using the Dako EnVision Flex detection system (DakoCytomation, Glostrup, Denmark), according to the manufacturer’s instructions. The Bright Vision detection system (IL Immunologic, Duiven, The Netherlands), with a Romulin AEC for antigen detection (BioCare Medical, Pacheco, CA, U.S.A.), was used for the manual stainings. The antibodies (Ab) used and the pretreatment strategies applied are listed in Table 1.

Immunohistochemical stains

AntibodyCloneCompany/CodeDilutionPretreatment
Amyloid β (Aβ)6F/3DDako-Agilent/M08721:5098–100% FA
Embryonic lethal abnormal visual system proteins (nELAV) 3 and 4 human homolog HuC/HuD (HuC/HuD)16A11ThermoFisher Scientific/A-212711:2000ac, CB
NEUronal Nuclei (NeuN)A60Milipore/MAB3771:2000CB
Hyperphosphorylated (Ser202/Thr205) τ (TAU8)PHF-TAU-AT8Fisher Sientific-Invitrogen/MN10201:1000
Synaptophysin (SYP)SY38Dako-Cytomation/M07761:50CB

Dako Autostainer Plus (Dako Cytomation) was used for Aβ, Tau8 and SYP, while the HuC/HuD and NeuN were carried out manually, incubation at room temperature for 1 h. Autoclave (ac), formic acid (FA), citrate buffer pH 6.0 (CB)

+ Open protocol
+ Expand
5

Histological Diagnosis and Immunohistochemical Profiling of Adrenocortical Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histologic diagnosis of ACC was performed by reference pathologist on tumor tissue removed at surgery. Tumor specimens were evaluated according to the Weiss System where the presence of three or more criteria highly correlates with malignant behavior [34 ].
Ki67 index was evaluated as proliferation marker to assess ACC prognosis using anti-human Ki67 monoclonal MIB1 antibody (Dako, Carpenteria, CA, US). Ki67 positive nuclei were counted on 1.000 tumor cells and Ki67 was expressed as the percentage of proliferating cells.
Tumor stage was evaluated according to the revised TNM classification of ACC proposed by the European Network for the Study of Adrenal Tumors [13 (link)].
For immunohistochemical analysis, section of 3μm were deparaffinized, hydrated with grade ethanol concentrations until distilled water. Serial sections of the same specimen were immunostained with mouse monoclonal anti-ALDH6A1, anti-Fascin-1, anti-CAP-1, anti-Lamin A/C, anti-Ferredoxin-reductase, anti-Transferrin (dilution 1:50) antibodies after treatement with 3.0% hydrogen peroxidase in PBS (Dako Wash Buffer 10x). Immunohistochemical analysis was carried out using DAKO EnVision™ FLEX (Dako, Carpenteria, CA, US).. Negative control was performed with a non-immune serum.
+ Open protocol
+ Expand
6

Immunohistochemical Analysis of Myb Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining for Myb was performed using the Dako EnVision+ System (Dako, Glostrup, Denmark). Briefly, 4um TMA sections were deparaffinized with xylene and ethanol. Heat-induced epitope retrieval was completed with EnVision Module at 97 °C for 20 min in pH 9.0 buffer. Endogenous peroxidase activity was blocked with Dako EnVision Flex. Tissue sections were then incubated with an anti-Myb monoclonal antibody (Genetex, Irvine, CA). The reaction was visualized using the Dako EnVision Flex+ System. External positive and negative controls were performed.
Myb was scored based on both % cells staining and the intensity of staining. The % of cells showing any staining was visually assessed along with the intensity of Myb staining using a 3-point scale: (0: absent; 1: weak; 2: moderate; 3: intense). Scoring was performed by two independent board-certified pathologists (AvZ and SA) with discrepant scores re-examined by both observers to achieve a consensus score.
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of MCM3 and Ki-67

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was performed on tissue microarray sections of 4 μm thickness using a DAKO Omnis platform (Agilent Technologies, Santa Clara, CA). Heat-induced epitope retrieval was performed on board, followed by antibody incubation in Dako EnVision FLEX (Agilent Technologies, Santa Clara, CA). For MCM3, the DAKO Omnis protocol H30-X-30 was utilized with recombinant rabbit monoclonal anti-MCM3 antibody (dilution 1/1000, clone EPR7080, catalogue # ab128923; Abcam, Cambridge, UK). For Ki-67, the DAKO Omnis protocol L20-X-20 was used with mouse monoclonal anti-Ki-67 antibody (ready-to-use, clone Mib-1, catalogue # GA626; Agilent Technologies, Santa Clara, CA). Nuclear expression in tumor cells was scored in 5% increments. Based on the distribution, no naturally occurring cut-off was apparent. Therefore, scores were categorized into 3 relatively equally sized groups after several iterations to optimize for prognostic stratification (For MCM3: <40%, 40% to 75%, >75%; for Ki-67 <20%, 20% to 30%, >30%). TMA cores with less than 10% tumor content were excluded from study. A subset of cases was scored again by a second observer blinded to the initial scores. Previously generated immunohistochemical and chromogenic in situ hybridization (CISH) data for p53, p16, RB1, and CCNE1 were used for correlative analysis [5 (link), 18 (link), 21 (link)].
+ Open protocol
+ Expand
8

Immunohistochemical Detection of PD-L1 in Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Slides were stained for routine diagnostics, over a period of several years. Formalin‐fixed paraffin‐embedded blocks were cut into 3‐µm sections with a Leica RM2255 Automated Microtome (Leica Biosystems B.V., Amsterdam, the Netherlands). Sections were placed on microscope slides and dried at either 60°C for 30 min to 16 h, or at 37°C for 72 h. After being dried, the slides were deparaffinised, and antigen retrieval was performed in citrate buffer (Target Retrieval Solution, pH 6) for 40 min. Immunohistochemistry (IHC) was performed according to a laboratory‐developed test protocol. Slides were stained with the Dako Omnis immunostainer and Dako EnVision Flex+ reagents and 1:20 dilution of PD‐L1 clone 22C3 (Dako Omnis, Dako Agilent Technologies, Leuven, Belgium). The IHC slides were then counterstained with haematoxylin, and coverslips were applied. Tonsil and placental tissue were used as positive controls for PD‐L1 expression.
+ Open protocol
+ Expand
9

Immunohistochemical Analysis of Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
FFPE pUM and mUM samples were sectioned at 4 μm thickness and underwent antigen retrieval using the Dako pretreatment module (Agilent Technologies UK Ltd, Stockport, UK); slides were then incubated in a high‐pH bath containing Tris/EDTA buffer, pH 9.0 (Dako EnVision™ FLEX, Agilent) at 96°C for 20 min. IHC was performed using a Dako Autostainer PLUS machine, using the Dako EnVision™ FLEX Kit (Agilent) according to the manufacturer's instructions. Slides were incubated with the following antibodies for 30 min: BAP1 (cat. No sc‐28 383/C‐4, dilution 1:200; Santa Cruz Biotechnology, Dallas, TX, USA), CD3 (cat. No IR503/polyclonal, ready to use; Dako Cytomation, CA, USA), CD4 (cat. No NCL‐L‐CD4/368, dilution 1:20; Leica Biosystems, Lincolnshire, IL, USA), CD8 (cat. No M7103/ C8/144B, dilution 1:200; Dako), CD163 (NCL‐L‐CD163/10D6, dilution 1:400; Leica Biosystems), and CD38 (NCL‐L‐CD38‐290/SPC32, dilution 1:100; Leica Biosystems).
The sections were counterstained with haematoxylin. Additional sections were treated with isotype controls at the same concentration as the primary antibodies.
+ Open protocol
+ Expand
10

Elastin Expression in Human Lungs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Elastin immunohistochemistry was performed to evaluate the expression of elastin in human lung tissues. Briefly, mouse anti-elastin antibody (ab77804, Abcam) was incubated with human lung tissues for 60 min after blocking. Tissues were washed and subjected to DAKO Envision FLEX (Agilent Technologies, Inc. Santa Clara, CA). After the tissues were washed, DAB was used as the chromogen. Then, the tissues were washed again and stained by Mayer's hemalum solution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!